Unlike HR-negative/HER2-positive (HR-/HER2+) breast cancer in which 74% is HER2-enriched subtype, the HER2-enriched subtype, and luminal-like subtype each account for about half of the HR+/HER2+ breast cancer (5). The gene discussed is ERBB2; the disease is breast carcinoma.